Capricor Therapeutics, Inc.CAPRNASDAQ
Loading
EPS Growth Under PressureDecelerating
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P14
Within normal range
vs 5Y Ago
-1.7x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-96.52%
2024-38.55%
202329.66%
2022-35.63%
20211.14%
202057.28%
201960.15%
2018-617.00%
2017109.86%
2016-25.34%